A Study to Evaluate Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Multiple Doses of VIS954
Clinical trial NCT06937593 · COMPLETED
Trial details
- NCT number
- NCT06937593
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-13
- Primary completion
- 2026-02-03
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.